Cost-effectiveness ratio (per case of tuberculosis avoided) of BCG vaccination of infants followed up to the age of 15 years in Finland (taken from data from Hersh et al., 2003)

Number of cases/100,000Cost effectiveness ratio (US $) per case avoided
ExpectedAvoidedSelective versus noneGeneralised versus selective
No vaccination42
Selective vaccination:
population at x 2 risk3667,1465,089
population at x 5 risk30122,5257,104
population at x 10 risk241893710,537
population at x 20 risk192316417,153
population at x 30 risk1626benefits24,045
population at x 50 risk1329benefits38,311
Generalised vaccination834

From: Tuberculosis: Place of vaccination in control of the disease

Cover of Tuberculosis: Place of vaccination in control of the disease
Tuberculosis: Place of vaccination in control of the disease [Internet].
INSERM Collective Expertise Centre.
Copyright © 2004, Institut national de la santé et de la recherche médicale (INSERM)

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.